↓ Skip to main content

Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia

Overview of attention for article published in Harm Reduction Journal, August 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#49 of 559)
  • High Attention Score compared to outputs of the same age (95th percentile)

Mentioned by

blogs
1 blog
twitter
69 tweeters

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia
Published in
Harm Reduction Journal, August 2018
DOI 10.1186/s12954-018-0248-4
Pubmed ID
Authors

Annie Madden, Max Hopwood, Joanne Neale, Carla Treloar

Abstract

Recent advances in the treatment of hepatitis C virus (HCV) infection provide the possibility of eliminating HCV as a public health threat. This focus on HCV elimination through treatment, however, is also driving a concomitant focus on 'achieving cure' as the primary outcome of treatment. The aim of this paper is to explore what people who inject drugs consider to be important in relation to outcomes of HCV treatment, and whether there are outcomes 'beyond cure' that might be important to understand as part of improving engagement in treatment. A peer researcher with experience of both HCV treatment and injecting drug use conducted interviews with 24 people in the following groups in Melbourne, Australia: (1) people who had refused or deferred HCV treatment; (2) people who were actively thinking about, planning and/or about to commence HCV treatment; (3) people currently undertaking HCV treatment and (4) people who had recently completed HCV treatment. The findings show that people who inject drugs are seeking outcomes 'beyond cure' including improved physical and mental health, positive changes in identity and social relationships and managing future health and risk. Participants indicated that these other outcomes had not been addressed within their experience of HCV treatment. While cure is an obvious outcome of HCV treatment, patients are seeking change in other areas of their lives. This study also provides valuable insights for the development of patient-reported measures in this context, which would be an important step towards more patient-centred approaches to HCV treatment.

Twitter Demographics

The data shown below were collected from the profiles of 69 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 28%
Student > Ph. D. Student 3 12%
Student > Master 3 12%
Other 1 4%
Student > Bachelor 1 4%
Other 1 4%
Unknown 9 36%
Readers by discipline Count As %
Nursing and Health Professions 3 12%
Social Sciences 2 8%
Immunology and Microbiology 1 4%
Agricultural and Biological Sciences 1 4%
Psychology 1 4%
Other 2 8%
Unknown 15 60%

Attention Score in Context

This research output has an Altmetric Attention Score of 53. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2019.
All research outputs
#370,222
of 14,498,896 outputs
Outputs from Harm Reduction Journal
#49
of 559 outputs
Outputs of similar age
#11,314
of 228,188 outputs
Outputs of similar age from Harm Reduction Journal
#1
of 1 outputs
Altmetric has tracked 14,498,896 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 559 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.4. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,188 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them